Molecular characterization and genetic mutations driving breast cancer in Rwandan population

Principal investigator: Clarisse MUSANABAGANWA
Check PI profile

Investigators

Clarisse MaMusanabaganwa, Jean Baptiste Mazarati, Leon Mutesa, Francis Makokha , Noela Bigirimana, Ivan Mwikarago,

Study information

  • Research Area: Cancer
  • Research type: Hospital-based epidemiological retrospective study and a subsequent case-control experimental study
  • Start date: Feb 01, 2019
  • End date: Dec 12, 2020

Study aim of the objectives

The study aims to identify breast cancer genetic mutations and characterize ER, PR receptor status, and HER2 overexpression in Rwandan breast cancer patients.

Study setting/Area (Location)

CHUK, RMH, CHUB, KFH, Butaro hospital

Implementing institution

Rwanda Biomedical Center

Department/Division

Medical Research Centre

Impact on Policy

Study implementation progress

Related research

Login
Support